RU2387448C2 - Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии - Google Patents

Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии Download PDF

Info

Publication number
RU2387448C2
RU2387448C2 RU2006140277/14A RU2006140277A RU2387448C2 RU 2387448 C2 RU2387448 C2 RU 2387448C2 RU 2006140277/14 A RU2006140277/14 A RU 2006140277/14A RU 2006140277 A RU2006140277 A RU 2006140277A RU 2387448 C2 RU2387448 C2 RU 2387448C2
Authority
RU
Russia
Prior art keywords
ethyl ester
acid
eicosanpentanoic
docosanhexanoic
acid ethyl
Prior art date
Application number
RU2006140277/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2006140277A (ru
Inventor
Сес-Нико ВЕРБОМ (DE)
Сес-Нико ВЕРБОМ
Райнер ЁЛЬЦЕ (DE)
Райнер ЁЛЬЦЕ
Original Assignee
Зольвай Фармасьютиклз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зольвай Фармасьютиклз Гмбх filed Critical Зольвай Фармасьютиклз Гмбх
Publication of RU2006140277A publication Critical patent/RU2006140277A/ru
Application granted granted Critical
Publication of RU2387448C2 publication Critical patent/RU2387448C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2006140277/14A 2004-04-16 2005-04-15 Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии RU2387448C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101578.5 2004-04-16
EP04101578 2004-04-16

Publications (2)

Publication Number Publication Date
RU2006140277A RU2006140277A (ru) 2008-05-27
RU2387448C2 true RU2387448C2 (ru) 2010-04-27

Family

ID=34928968

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006140277/14A RU2387448C2 (ru) 2004-04-16 2005-04-15 Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии

Country Status (12)

Country Link
EP (1) EP1765319A1 (fr)
JP (1) JP2007532605A (fr)
CN (1) CN1942180A (fr)
AU (1) AU2005244483B2 (fr)
BR (1) BRPI0509878A (fr)
CA (1) CA2504280A1 (fr)
IL (1) IL178300A0 (fr)
MX (1) MX291518B (fr)
RU (1) RU2387448C2 (fr)
UA (1) UA94693C2 (fr)
WO (1) WO2005110393A1 (fr)
ZA (1) ZA200607794B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2421909A (en) * 2004-12-23 2006-07-12 Laxdale Ltd Pharmaceutical compositions comprising EPA and methods of use
ITMI20100961A1 (it) * 2010-05-27 2011-11-28 Erredue Spa Miscele ricche in esteri di acidi grassi omega-3, loro composizioni e loro processo di preparazione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7222598A (en) * 1997-04-29 1998-11-24 Scotia Holdings Plc Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
WO2002096408A1 (fr) * 2001-05-30 2002-12-05 Laxdale Limited Coenzyme q et acide eicosapentaenoique (epa)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
СУМАРОКОВ А.В. и др. Клиническая кардиология. - М.: «Универсум Паблишинг», 1995, с.6, 13, 65-70. McLENNAN P. et al. "The cardiovascular protective role of docosahexaenoic acid". Eur J Pharmacol. 1996 Apr 4; 300 (1-2): 83-9, реферат. TURNER N et al. "Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism". Naturwissenscaften 10.10.2003, p.p.521-523. *

Also Published As

Publication number Publication date
MXPA06011940A (es) 2006-12-15
CN1942180A (zh) 2007-04-04
EP1765319A1 (fr) 2007-03-28
AU2005244483A1 (en) 2005-11-24
JP2007532605A (ja) 2007-11-15
WO2005110393A1 (fr) 2005-11-24
MX291518B (es) 2011-10-31
UA94693C2 (ru) 2011-06-10
CA2504280A1 (fr) 2005-10-16
RU2006140277A (ru) 2008-05-27
ZA200607794B (en) 2008-05-28
AU2005244483B2 (en) 2011-06-09
BRPI0509878A (pt) 2007-10-16
IL178300A0 (en) 2007-02-11

Similar Documents

Publication Publication Date Title
JP5441287B2 (ja) 心血管事象を予防するための必須脂肪酸
JP5827784B2 (ja) ビタミンｋ２を含む医薬及び栄養補助製品
US4874603A (en) Use of vitamin E for normalization of blood coagulation during therapy with high unsaturated fatty acids of omega-3 type
ES2576578T3 (es) Composición de ácidos grasos n-3 que presentan una concentración elevada de EPA y/o DHA y que contiene ácidos grasos n-6
MXPA05009432A (es) Uso de acidos grasos omega-3 en el tratamiento de pacientes diabeticos.
UA78693C2 (en) Use of eicosapentaenoic acid ethyl ester and docosahexaenoic acid ethyl ester for treating heart failure
IL91275A (en) Fatty acid preparation consisting mainly of acid (Z-LLA) (-5, 8, 11, 41, 71, Icozapentanoic acid) and Z-LLA (-4,7,01, 31, 61, 91) - Docosahexa
EP0321128A1 (fr) Compositions d'acide gras
WO2003068216A1 (fr) Utilisation d'esters ethyliques d'acides polyinsatures omega 3 chez des patients atteints d'une insuffisance cardiaque
WO1995017889A1 (fr) Composition therapeutique utile pour traiter l'hyperparathyroidie d'un patient en dialyse artificielle
US8114906B2 (en) Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease
RU2387448C2 (ru) Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии
US20040235948A1 (en) Treatment of diabetic patients with omega-3-fatty acids
US9808437B2 (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
US11039997B2 (en) Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
JP2007532605A5 (fr)
JPS59175425A (ja) 脳卒中予防剤
JPH11239464A (ja) 運動時の危険因子除去能を有する組成物
JPH07233062A (ja) 人工透析患者の皮膚そう痒症治療組成物及び副甲状腺機能亢進症治療組成物
GB2620543A (en) Composition for use
JP5570172B2 (ja) 喫煙による循環機能不全の予防／改善または治療剤

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140416